To date, most cell types in mammalian organs have been identified and categorized based upon histological and histochemical features. It has become clear that within these broad histological categories, there reside subpopulations of cell types that exhibit distinct gene expression profiles and consequently have unique functional attributes. We hypothesize that functionally-distinct cell types comprising the human prostate and bladder can be identified and isolated based upon unique profiles of proteins found on the cell surface or in secretory vesicles. These proteins will comprise what we propose to term the Urological Cluster Differentiation (UCD) system. Through an iterative process, we propose to sequentially isolate increasingly pure populations of genetically-homogenous cell types that comprise tissues representing normally functioning organs. We further hypothesize that cells expressing surface or secretory proteins deviating from cell profiles established as normal, represent additional cell types with pathological behavior (e.g. malignancy, scarring). To test these hypotheses we will:
Aim 1. Characterize the repertoire of cell surface and secreted proteins expressed by rt/sto/og/ca//y-distinct cell types comprising the epithelium and stromal constituents of the human and mouse prostate and bladder.
Aim 2. Develop and validate a panel of Urological Clusters of Differentiation (UCD) Markers suitable for identifying and isolating distinct cell types comprising the prostate and bladder. This will comprise the first iteration of the Urological Cluster Designation (UCD) system. Further iterations of UCDs will be developed based upon the heterogeneous expression of additional UCDs within the original 'homogeneous' populations.
Aim 3. Characterize functional differences in cell types defined by the Urological Cellular Differentiation (UCD) System. These studies will involve the evaluation of in vitro growth characteristics, cellular gene expression, organ topography, inter-species conservation, and transgenic animal models.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK069690-03
Application #
7341147
Study Section
Special Emphasis Panel (ZRG1-RUS-D (50))
Program Officer
Hoshizaki, Deborah K
Project Start
2006-04-01
Project End
2009-12-31
Budget Start
2008-01-01
Budget End
2008-12-31
Support Year
3
Fiscal Year
2008
Total Cost
$326,252
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Meng, Jing; Mostaghel, Elahe A; Vakar-Lopez, Funda et al. (2011) Testosterone regulates tight junction proteins and influences prostatic autoimmune responses. Horm Cancer 2:145-56
Bianchi-Frias, Daniella; Vakar-Lopez, Funda; Coleman, Ilsa M et al. (2010) The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS One 5:
Mecham, Brigham H; Nelson, Peter S; Storey, John D (2010) Supervised normalization of microarrays. Bioinformatics 26:1308-15
Holcomb, Ilona N; Young, Janet M; Coleman, Ilsa M et al. (2009) Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer. Cancer Res 69:7793-802
Pritchard, Colin; Mecham, Brig; Dumpit, Ruth et al. (2009) Conserved gene expression programs integrate mammalian prostate development and tumorigenesis. Cancer Res 69:1739-47
Lucas, J M; True, L; Hawley, S et al. (2008) The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. J Pathol 215:118-25
Dean, J P; Nelson, P S (2008) Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis. Br J Cancer 98:245-9
Pritchard, Colin C; Nelson, Peter S (2008) Gene expression profiling in the developing prostate. Differentiation 76:624-40
Pascal, Laura E; True, Lawrence D; Campbell, David S et al. (2008) Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 9:246